Heads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...

India's diabetes and weight-loss drug market is set for a major shift. Novo Nordisk's popular drug semaglutide is now off patent. Over 40 c...

Reuters spoke to three-dozen people inside the industry including retailers, drugmakers, telehealth providers and investors to show how the...

Morepen Laboratories plans to significantly expand its medical representative team, adding over 1,000 members in the next three years, with...

Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lil...

Industry executives and headhunters told ET that salesforce is needed as they launch more products targeting chronic therapeutic segments s...

The drugmaker said Monday that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by...

The better than expected profitable growth led to the stock closing up over 3%. However, the growth in India and US businesses — each accou...

The drugs –– Bedaquiline by US drugmaker J&J and Delamanid by Japanese drugmaker Otsuka Pharma –– are the only treatment option for patient...

Srivastava of Boehringer Ingelheim India added that there is strong demand for medicine and other health products in India.

Police charged Mark Reilly with multiple offences after a 10-month probe found the firm made billions of yuan from schemes to bribe doctors.

Mark Reilly and two Chinese executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry.

Drugmakers from GlaxoSmithKline to Lupin are grappling with distributors, whose demand for maintaining commissions threatens to erode profi...

The companies give patients more than just the daily dose, helping them with counselling, diagnostic tests, freebies, diet or exercise advi...

Pfizer will pay $2.3 bn to settle a US investigation into illegal marketing of medicines, the largest agreement in such a case, and a subsi...

Pfizer, the world’s largest drugmaker, said third-quarter profit fell 77% on costs for ending sales of the diabetes treatment Exubera and c...

Sanofi-aventis reported a 12% drop in third-quarter profit on Tuesday, citing the loss of top-selling blood thinner Plavix to generic compe...